investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Preclinical Evaluation of Novel Therapeutics for CNS Tumor Therapy

Katherine Warren

1 Collaborator(s)

Funding source

National Cancer Institute (NIH)
Collaborating with SU2C team in evaluating agents for therapeutic intent in children with CNS tumors. Plan to evaluate azacytidine and decitabine in our nonhuman primate model.

Related projects

Robert C Castellino

Mechanisms of PPM1D in Medulloblastoma Tumorigenesis and Invasion

Brain, nervous system

Stephan Maier

Advanced Techniques For Rapid And Artifact-Resistant MR Diffusion Imaging

Brain, nervous system

Harold M Swartz

Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy

Brain, nervous system

Radiation Oncology

Wei Zhang

Characterization of oncogenic FGFR3-TACC3 fusion gene in glioblastoma

Brain, nervous system

Nicholas Mitsiades

REGULATION OF UVEAL MELANOMA CELL FATE BY THE PKC PATHWAY VIA MITF

Brain, nervous system

Joseph H Mccarty

Deciphering mechanisms of perivascular tumor cell invasion in glioblastoma

Brain, nervous system

Scott M Welford

Polyamine Catabolism and Therapeutic Resistance in Glioblastoma Multiforme

Brain, nervous system

Radiation Oncology

Bingwei Lu

Genetic Control of Neural Stem Cell Homeostasis

Brain, nervous system

Michael Gottesman

Genetic Analysis of the Multidrug Resistance Phenotype in Tumor Cells

Brain, nervous system